Vitamin D and Type 2 Diabetes - a Cross Sectional Study
Status
Conditions
Details and patient eligibility
About
The purpose of the study is to describe vitamin D status among patients with type 2 diabetes and to determine the association between serum 25-hydroxyvitamin D and glycemic control, markers of inflammation and blood pressure
Full description
It has been estimated that 1 billion people worldwide have vitamin D deficiency or insufficiency. It is well known that vitamin D deficiency causes osteoporosis, increases the risk of fracture and causes muscle weakness. But there is now evidence that calcium malnutrition and hypovitaminosis D are predisposing conditions for various common chronic diseases such as malignancies (particularly colon, breast and prostate) chronic inflammatory and autoimmune disease (inflammatory bowel disease, multiple sclerosis) as well as metabolic disorders (metabolic syndrome, hypertension).
It has also been reported that vitamin D deficiency may predispose to glucose intolerance, altered insulin secretion and type 2 diabetes mellitus.
The purpose of this study is to determine vitamin D status among type 2 diabetics in our outpatient clinic and examine the relationship between vitamin D status , calcium and phosphorous metabolism, inflammatory markers, glycemic control, blood pressure and lipid profile.
Moreover the patients are asked to answer a questionnaire regarding lifestyle, exercise, sun exposure and food intake.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Type 2 diabetes mellitus
- Patients of Danish extraction
- Written consent
Exclusion criteria
- Renal failure (Urea > 12 mmol/l)
- Age < 18 years
- malabsorption
Trial design
150 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal